Axial VC — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Inductive Bio builds AI and machine learning software to accelerate drug discovery for pharmaceutical and biotech researchers, combining computational chemistry with expertise in translating complex drug programs from preclinical to clinical stages.
AI & Machine LearningBiotechDeep TechBrooklyn, US
Josh Haimson(Executive Officer, Director)inBen Birnbaum(Ph.D.)inAlexander Taylor(Ph.D.)in
BoardRohan Ganesh(Director)in
Co-investorsAlleyCorpAndreessen HorowitzCoalition OperatorsLux CapitalObvious VenturesAlley Robotics Ventures+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.